Skip to main content

Table 2 Forecasting the prevalence (95 % confidence interval) of MS from 2020 to 2029 (prevalence in 100,000 population)

From: Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series

Year

Total MS

Familial MS

Sporadic MS

2020

189.50(183.94-195.14)

25.69(24.97–26.45)

163.74(159.06-168.57)

2021

193.00(184.6-201.28)

26.26(25.18–27.39)

166.6(159.61-173.82)

2022

196.50(184.42-208.02)

26.83(25.23–28.35)

169.45(159.15-179.16)

2023

199.97(183.79-215.27)

27.4(25.24–29.49)

172.32(158.38-185.68)

2024

203.45(182.7-222.98)

27.96(25.17–30.61)

175.11(157.29-192.05)

2025

206.93(181.19-231.26)

28.53(25.1-31.83)

177.96(155.73-199.19)

2026

210.41(179.31-239.54)

29.09(24.92–33.11)

180.82(154.02–206.5)

2027

213.87(176.92-248.41)

29.66(24.72–34.46)

183.63(151.76-214.43)

2028

217.36(174.36–257.50)

30.23(24.47–35.72)

186.51(149.58-221.73)

2029

220.84(171.48-266.92)

30.79(24.16–37.15)

189.33(146.97-230.19)